GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment

Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Sun Pharmaceutical Industries Ltd
Sun Pharma's 'CRISIL AAA/Stable' Rating Reaffirmed by CRISIL
RATING ▲ Positive Development LOW RISK
📅 Filed on BSE: 05 Aug 2026, 09:18 AM IST  ·  BSE ID: 7a39b83d-db60-43f6-9850-5ac9ba496a42
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's top credit rating has been confirmed and is now considered stable by the rating agency.
🤖 AI Summary
  • CRISIL reaffirmed Sun Pharma's long-term bank facilities rating at 'CRISIL AAA'.
  • The rating watch with developing implications has been removed by CRISIL.
  • The credit rating now carries a 'Stable' outlook.
  • This update pertains to the company's long-term bank facilities.
  • The earlier rating watch was initiated on 07 May 2026.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Rating
CRISIL AAA/Stable
Previous Rating Watch Status
Rating Watch with Developing Implications
Rating Watch Initiation Date
07 May 2026
🏢 How This Affects the Company
💰
Financial Impact
A stable, top-tier credit rating assists in maintaining favorable borrowing costs and access to capital markets for ongoing operations and strategic initiatives.
⚠️
Risk Impact
Removal from rating watch with developing implications signifies a reduction in perceived immediate uncertainty regarding the company's credit profile.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders regarding this rating update.
👤
Who Is Affected
All shareholders are indirectly affected by the company's maintained strong credit profile, which supports financial stability.
🔍
Management Signal
This reaffirms management's commitment to maintaining robust financial health and credit discipline.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Next annual credit rating review by CRISIL.
Future financial results announcements.
Any significant corporate actions impacting credit metrics.
LOW RISK The rating is reaffirmed at the highest grade, indicating minimal credit risk.
💡 Investor Takeaway
Sun Pharma's long-term bank facilities rating is reaffirmed at 'CRISIL AAA/Stable' by CRISIL, removing prior watch status and confirming strong creditworthiness.
⚖️ Strengths & Concerns

✅ Positives

  • Reaffirmation of 'CRISIL AAA' rating indicates strong creditworthiness and financial stability.
  • Stable outlook suggests no immediate concerns regarding the company's ability to meet financial obligations.
❓ Frequently Asked Questions
What is Sun Pharmaceutical Industries Limited's updated credit rating?
Sun Pharmaceutical Industries Limited's long-term bank facilities have been reaffirmed at 'CRISIL AAA/Stable' by CRISIL Ratings.
Has the 'Rating Watch with Developing Implications' been removed for Sun Pharma?
Yes, CRISIL Ratings has removed the 'Rating Watch with Developing Implications' status for Sun Pharmaceutical Industries Limited.
When was the rating watch with developing implications initially placed on Sun Pharma's rating?
The rating watch with developing implications was initially placed on Sun Pharmaceutical Industries Limited's rating on 07 May 2026.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.